A catalog of prostate cancer nomograms
- PMID: 11342918
A catalog of prostate cancer nomograms
Abstract
Purpose: Prediction is central to the management of prostate cancer. Nomograms are devices that make predictions. We organized many nomograms for prostate cancer.
Materials and methods: Using MEDLINE a literature search was performed on prostate cancer nomograms from January 1966 to February 2000. We recorded input variables, prediction form, the number of patients used to develop the nomogram and the outcome being predicted. We also recorded the accuracy measures reported by the original authors and whether the nomograms have withstood validation. In addition, we noted whether the nomograms were proprietary or in the public domain. Each nomogram was classified into patient clinical disease state and the outcome being predicted.
Results: The literature search generated 42 published nomograms that may be applied to patients in various clinical stages of disease. Of the 42 nomograms only 18 had undergone validation, of which 2 partially failed. Few nomograms have been compared for predictive superiority and none appears to have been compared with clinical judgment alone.
Conclusions: Patients with prostate cancer need accurate predictions. Prognostic nomograms are available for many clinical states and outcomes, and may provide the most accurate predictions currently available. Selection among them and progress in this field are hampered by the lack of comparisons for predictive accuracy.
Similar articles
-
An updated catalog of prostate cancer predictive tools.Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908. Cancer. 2008. PMID: 18823041 Review.
-
Inventory of prostate cancer predictive tools.Curr Opin Urol. 2008 May;18(3):279-96. doi: 10.1097/MOU.0b013e3282f9b3e5. Curr Opin Urol. 2008. PMID: 18382238 Review.
-
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.Clin Cancer Res. 2008 Jul 15;14(14):4400-7. doi: 10.1158/1078-0432.CCR-07-4713. Clin Cancer Res. 2008. PMID: 18628454 Review.
-
Nomograms for bladder cancer.Eur Urol. 2008 Jul;54(1):41-53. doi: 10.1016/j.eururo.2008.01.004. Epub 2008 Jan 15. Eur Urol. 2008. PMID: 18207314 Review.
-
Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.Cancer. 2009 Jul 1;115(13 Suppl):3039-45. doi: 10.1002/cncr.24355. Cancer. 2009. PMID: 19544545
Cited by
-
What's a man to do? Treatment options for localized prostate cancer.Can Fam Physician. 2004 Jan;50:65-72. Can Fam Physician. 2004. PMID: 14761106 Free PMC article. Review.
-
Advances in the Medical Treatment of Prostate Cancer, Bladder Cancer, Renal Cell Cancer, and Benign Prostatic Hyperplasia: Highlights from the XVIIth Congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002.Rev Urol. 2003 Spring;5(2):90-110. Rev Urol. 2003. PMID: 16985626 Free PMC article. No abstract available.
-
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1928-36. doi: 10.1158/1055-9965.EPI-11-0236. Epub 2011 Aug 16. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21846818 Free PMC article.
-
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy.J Clin Oncol. 2005 Mar 20;23(9):1962-8. doi: 10.1200/JCO.2005.06.058. J Clin Oncol. 2005. PMID: 15774789 Free PMC article.
-
Role of nomograms for prostate cancer in 2007.World J Urol. 2007 Apr;25(2):131-42. doi: 10.1007/s00345-007-0146-y. Epub 2007 Feb 27. World J Urol. 2007. PMID: 17333203 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical